Case Report: A Case of Sintilimab-Induced Cystitis/Ureteritis and Review of Sintilimab-Related Adverse Events

Immune checkpoint inhibitors (ICIs) have been proven to be beneficial in multiple advanced malignancies. However, the widespread use of ICIs also occurred with various immune-related adverse events (irAEs). Here, we first report a case of sintilimab-related cystitis/ureteritis. A 53-year-old man wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Lingfang, Ye, Yuan, Tang, Xiaoping, Liang, Zhen, You, Qihan, Zhou, Jianying, Pan, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733470/
https://www.ncbi.nlm.nih.gov/pubmed/35004277
http://dx.doi.org/10.3389/fonc.2021.757069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733470/
https://www.ncbi.nlm.nih.gov/pubmed/35004277
http://dx.doi.org/10.3389/fonc.2021.757069

Ejemplares similares